Shokoofe Noori Selected Research

tehranolide

1/2024	Correction: Curcumin potentiates the anti-inflammatory effects of Tehranolide by modulating the STAT3/NF-κB signaling pathway in breast and ovarian cancer cell lines.
10/2023	Curcumin potentiates the anti-inflammatory effects of Tehranolide by modulating the STAT3/NF-κB signaling pathway in breast and ovarian cancer cell lines.
10/2023	Tehranolid and Artemisinin Effects on Ameliorating Experimental Autoimmune Encephalomyelitis by Modulating Inflammation and Remyelination.
1/2014	Tehranolide inhibits cell proliferation via calmodulin inhibition, PDE, and PKA activation.
5/2012	Tehranolide inhibits proliferation of MCF-7 human breast cancer cells by inducing G0/G1 arrest and apoptosis.
4/2010	Tehranolide molecule modulates the immune response, reduce regulatory T cell and inhibits tumor growth in vivo.
12/2009	Tehranolide could shift the immune response towards Th1 and modulate the intra-tumor infiltrated T regulatory cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shokoofe Noori Research Topics

Disease

23	Neoplasms (Cancer) 01/2024 - 12/2009
15	Breast Neoplasms (Breast Cancer) 10/2023 - 01/2010
5	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 01/2023
3	Inflammation (Inflammations) 10/2023 - 12/2013
2	Non-alcoholic Fatty Liver Disease 11/2023 - 01/2023
2	Hypersensitivity (Allergy) 05/2022 - 09/2010
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2024
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2023
1	Leukemia 01/2023
1	Osteoarthritis 12/2022
1	Thyroid Neoplasms (Thyroid Cancer) 01/2022
1	Ischemia 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Fibrosarcoma 06/2013

Drug/Important Bio-Agent (IBA)

7	tehranolideIBA 01/2024 - 12/2009
7	CytokinesIBA 10/2023 - 12/2009
5	artemisinin (artemisinine)IBA 10/2023 - 04/2010
5	Interleukin-4 (Interleukin 4)IBA 06/2013 - 01/2010
4	CurcuminIBA 01/2024 - 01/2023
4	naringeninIBA 01/2023 - 01/2020
3	ferroceneIBA 02/2022 - 01/2020
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 09/2010
3	sclareolIBA 01/2020 - 01/2010
2	Proteins (Proteins, Gene)FDA Link 01/2024 - 12/2013
2	ResveratrolIBA 11/2023 - 01/2022
2	Triglycerides (Triacylglycerol)IBA 11/2023 - 01/2023
2	LactonesIBA 10/2023 - 01/2014
2	SesquiterpenesIBA 10/2023 - 01/2014
2	Ketoprofen (Orudis)FDA LinkGeneric 01/2023 - 01/2021
2	Bromodeoxyuridine (BrdU)IBA 01/2011 - 04/2010
1	pyridineIBA 01/2024
1	Metformin (Glucophage)FDA LinkGeneric 11/2023
1	LipidsIBA 11/2023
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 10/2023
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 10/2023
1	Chalcone (Benzalacetophenone)IBA 01/2023
1	Arginine (L-Arginine)FDA Link 01/2023
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2023
1	LigandsIBA 01/2023
1	IntegrinsIBA 01/2023
1	Aspartic Acid (Aspartate)FDA Link 01/2023
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2023
1	Iodoacetic AcidIBA 12/2022
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 05/2022
1	cryptotanshinoneIBA 05/2022
1	FlavonoidsIBA 02/2022
1	Hormones (Hormone)IBA 01/2022
1	Zinc Oxide FDA Link 01/2022
1	SteroidsIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	8-hydroxydaidzeinIBA 01/2020
1	Staphylococcal Protein A (Protein A)IBA 12/2013
1	Membrane Proteins (Integral Membrane Proteins)IBA 12/2013
1	salvigeninIBA 11/2013
1	VaccinesIBA 06/2013
1	Propranolol (Inderal)FDA LinkGeneric 06/2013
1	Cyclin EIBA 05/2012
1	Cyclin D1IBA 05/2012
1	Artemether FDA Link 11/2011
1	artenimol (dihydroartemisinin)IBA 01/2011
1	Antimalarials (Antimalarial Agents)IBA 09/2010

Therapy/Procedure

8	Therapeutics 01/2023 - 04/2010
3	Immunotherapy 11/2013 - 04/2010
1	Aftercare (After-Treatment) 02/2022
1	Quantum Dots (Quantum Dot) 01/2022
1	Transplantation 01/2022
1	Liver Transplantation 01/2022
1	Drug Therapy (Chemotherapy) 01/2020
1	Intraperitoneal Injections 03/2013